Deal Announcements

Aldagen Secures $18 Million For Development

Friday, April 25, 2008 6:09:00 AM PDT | VentureDeal Staff

DURHAM, NC -- Biotechnology company Aldagen Inc. announced that it has received $18.4 million in new investment from a syndicate of venture capital firms.

Aldagen is a clinical stage regenerative medicine company developing treatments for vascular and degenerative diseases via adult stem and progenitor cell technologies.

Investors in the round included Intersouth Partners, Tullis-Dickerson & Co., Inc., Harbert Venture Partners and The Aurora Funds.

Aldagen said it would the proceeds to further advance the development pipeline for its four clinical-stage candidates.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1